646 Results

People

  1. O'Reilly
    O'Reilly
  2. Kernan
    Kernan
  3. Sadelain
    Sadelain
  4. Dupont
    Dupont
  5. Heller
    Heller
  6. Brentjens
    Brentjens
  7. Small
    Small
  8. Van Den Brink
    Van Den Brink
  9. Houghton
    Houghton
  10. Riviere
    Riviere

Groups

  1. Department of Medicine (309)
  2. GSK Faculty (256)
  3. Sloan Kettering Institute Faculty (235)
  4. Hematologic Malignancies, Division of (213)
  5. Center for Hematologic Malignancies (196)
  6. Immunology Program Faculty (145)
  7. Tow Center for Developmental Oncology (TCDO) (105)
  8. Pediatrics, Department of (96)
  9. Center for Molecular Imaging and Biotechnology (94)
  10. Hematologic Malignancies Research (90)
  1. "t-lymphocytes"
Formats
  1. Journal Article (599)
  2. Review (20)
  3. Editorial (14)
  4. Conference Paper (8)
  5. Correspondence (3)
  6. Guidelines (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (309)
  2. GSK Faculty (256)
  3. Sloan Kettering Institute Faculty (235)
  4. Hematologic Malignancies, Division of (213)
  5. Center for Hematologic Malignancies (196)
  6. Immunology Program Faculty (145)

More Groups

People
  1. Richard O'Reilly (65)
  2. Michel Sadelain (55)
  3. Marcel Van Den Brink (38)
  4. Nancy Kernan (32)
  5. Bo Dupont (31)
  6. Glenn Heller (31)

More People

Years
  1. 2025 (10)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (24)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Blood (52)
  2. Journal of Immunology (41)
  3. Journal of Experimental Medicine (38)
  4. Proceedings of the National Academy of Sciences of the United States of America (19)
  5. Clinical Cancer Research (16)
  6. Biology of Blood and Marrow Transplantation (15)

More Publications

Publishers
  1. Elsevier Inc. (73)
  2. Nature Publishing Group (65)
  3. American Society of Hematology (55)
  4. The American Association of Immunologists, Inc (41)
  5. Rockefeller University Press (38)
  6. American Association for Cancer Research (37)

More Publishers

Results (646)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GPRC5D-targeted CAR T cells for myeloma: The author's reply
    Correspondence

    Mailankody, S.; Brentjens, R. J.; Smith, E. L.
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
    Review

    Li, H.; Zhao, A.; Li, M.; Shi, L.; Han, Q.; Hou, Z.
    Frontiers in Immunology (2022)

    Fulltext@MSK | Save
  • Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
    Journal Article

    Golkaram, M.; Kuo, F.; Gupta, S.; Carlo, M. I.; Salmans, M. L.; Vijayaraghavan, R.; Tang, C.; Makarov, V.; Rappold, P.; Blum, K. A.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • Less, but better: A simplified design for T cell redirection and conditional payload delivery
    Editorial

    Kropp, K. N.; Klebanoff, C. A.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Clinical implications of T cell exhaustion for cancer immunotherapy
    Review

    Chow, A.; Perica, K.; Klebanoff, C. A.; Wolchok, J. D.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
    Journal Article

    van der Stegen, S. J. C.; Lindenbergh, P. L.; Petrovic, R. M.; Xie, H.; Diop, M. P.; Alexeeva, V.; Shi, Y.; Mansilla-Soto, J.; Hamieh, M.; Eyquem, J.; more...
    Nature Biomedical Engineering (2022)

    Fulltext@MSK | Save
  • First report of bilateral breast-implant associated anaplastic large cell lymphoma caused by identical T-cell clone
    Correspondence

    Stuver, R.; Lewis, N. E.; Ewalt, M. D.; Dogan, A.; Durham, B. H.; Plitas, G.; McCarthy, C.; Horwitz, S. M.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Role of CD19 chimeric antigen receptor T cells in second-line large B cell lymphoma: Lessons from phase 3 trials. An expert panel opinion from the American Society for Transplantation and Cellular Therapy
    Review

    Perales, M. A.; Anderson, L. D. Jr; Jain, T.; Kenderian, S. S.; Oluwole, O. O.; Shah, G. L.; Svoboda, J.; Hamadani, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies
    Journal Article

    Klatt, M. G.; Dao, T.; Yang, Z.; Liu, J.; Mun, S. S.; Dacek, M. M.; Luo, H.; Gardner, T. J.; Bourne, C.; Peraro, L.; more...
    Blood (2022)

    Fulltext@MSK | Save